Popular on TelAve
- Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026 - 316
- WhereTu Launches to Help Americans Build Successful Lives Abroad - 295
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed - 255
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy - 222
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine - 219
- Dentists launch independent platform to help practices choose the right technology - 165
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers
- 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
Similar on TelAve
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- Crossroads4Hope Announces The Lipschutz Women's Fund
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
BioLab Holdings, Inc. Launches Its Largest Clinical Trial to Date Evaluating Human Placental Membrane Products
TelAve News/10870861
PHOENIX, July 31, 2025 ~ Phoenix-based medical manufacturer, BioLab Holdings, Inc., has announced the launch of its most comprehensive clinical trial to date. The trial, titled "A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (BIOCAMP)," aims to evaluate the effectiveness of four human placental membrane (HPM) products in combination with standard of care (SOC) for treating nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on TelAve News
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
The trial will enroll 650 participants across up to 30 clinical sites nationwide. According to Dr. Marshall Medley, chief medical officer at BioLab, this study marks a significant milestone in their commitment to advancing wound care through rigorous clinical research. He stated that by evaluating their full suite of amnion-based products in a real-world setting, they hope to provide clinicians with robust data to guide treatment decisions for patients with chronic wounds.
More on TelAve News
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
Participants will be randomly assigned to receive one of four BioLab products – Tri-Membrane Wrap™ (HPM-1), Membrane Wrap™ (HPM-2), Membrane Wrap-Lite™ (HPM-3), or Membrane Wrap-Hydro™ (HPM-4) – in addition to SOC or SOC alone. Treatments will be applied weekly for up to 12 weeks or until complete wound closure is achieved and confirmed two weeks later. Optional weekly visits will allow for dressing changes in both study arms.
The study is designed to capture real-world clinical outcomes and contribute to the growing body of evidence supporting the use of placental-derived allografts in chronic wound management. For more information on BioLab Holdings, Inc. and its regenerative wound care solutions, interested parties can visit their website at biolabholdings.net.
0 Comments
Latest on TelAve News
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
- ForityCloud Launches Tandem, a Fully Managed Private Cloud for Businesses Ready to Scale
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- What's New in Hokkaido, Autumn 2026
- ASTPP Launches Carrier-Grade VoIP Billing Software for Wholesale Telecom Carriers
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- VoIP Supply Launches CloudSpan: A Brand-Agnostic Platform for PBX Licensing and Hosting Management
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Valgar LLC Launches The Briefing Room: Education Leaders
- New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
- New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
- Axis International Introduces the Smart Heated Floor Runner, Bringing Smart Comfort to Every Step
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy